ARCHIVES

Centers Eligible For Comprehensive Identification Names; Rauscher To Pick Four Now, Two More Later

This article is from The Cancer Letter archive.

Vol. 01 No. 16 | May 24, 1974

Download PDF Visit The Full Archive

Related Articles

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

Responses So Far Support Outstanding Investigator Grant; NCAB Members Object To Salary commitment

July 8, 1983

Regular Exercise May Prevent Cancer, Improve Survival

April 30, 2004

Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer

May 30, 2003